Old Web
English
Sign In
Acemap
>
authorDetail
>
Shigenori Kawasaki
Shigenori Kawasaki
Astellas Pharma
Medicine
Diabetes mellitus
Intensive care medicine
Hyperphosphatemia
Adverse effect
3
Papers
64
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized Controlled Trial of Bixalomer Versus Sevelamer Hydrochloride in Hemodialysis Patients With Hyperphosphatemia
2014
Therapeutic Apheresis and Dialysis
Tadao Akizawa
Hideki Origasa
Chisato Kameoka
Yuichiro Kaneko
Shigenori Kawasaki
Show All
Source
Cite
Save
Citations (22)
Long-term treatment of hyperphosphatemia with bixalomer in Japanese hemodialysis patients.
2013
Therapeutic Apheresis and Dialysis
Tadao Akizawa
Chisato Kameoka
Yuichiro Kaneko
Shigenori Kawasaki
Show All
Source
Cite
Save
Citations (12)
Ipragliflozin (ASP1941), a selective sodium-dependent glucose cotransporter 2 inhibitor, safely stimulates urinary glucose excretion without inducing hypoglycemia in healthy Japanese subjects
2011
Diabetology international
Takeshi Kadokura
Masako Saito
Atsushi Utsuno
Kenichi Kazuta
Satoshi Yoshida
Shigenori Kawasaki
Itsuro Nagase
Shigeru Kageyama
Show All
Source
Cite
Save
Citations (30)
1